These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 12721104

  • 1. AT1 receptor antagonist therapy preferentially ameliorated right ventricular function and phenotype during the early phase of remodeling post-MI.
    Nguyen QT, Colombo F, Clement R, Gosselin H, Rouleau JL, Calderone A.
    Br J Pharmacol; 2003 Apr; 138(8):1485-94. PubMed ID: 12721104
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin type 1 receptor antagonism with irbesartan inhibits ventricular hypertrophy and improves diastolic function in the remodeling post-myocardial infarction ventricle.
    Ambrose J, Pribnow DG, Giraud GD, Perkins KD, Muldoon L, Greenberg BH.
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):433-9. PubMed ID: 10069680
    [Abstract] [Full Text] [Related]

  • 3. Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.
    Fraccarollo D, Galuppo P, Schmidt I, Ertl G, Bauersachs J.
    Cardiovasc Res; 2005 Jul 01; 67(1):97-105. PubMed ID: 15949473
    [Abstract] [Full Text] [Related]

  • 4. [Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase].
    Zhang RY, Huang YL, Sun YH.
    Zhonghua Yi Xue Za Zhi; 2005 Apr 20; 85(15):1053-6. PubMed ID: 16029550
    [Abstract] [Full Text] [Related]

  • 5. AT1 receptor blockade prevents cardiac dysfunction after myocardial infarction in rats.
    Berthonneche C, Sulpice T, Tanguy S, O'Connor S, Herbert JM, Janiak P, de Leiris J, Boucher F.
    Cardiovasc Drugs Ther; 2005 Aug 20; 19(4):251-9. PubMed ID: 16193242
    [Abstract] [Full Text] [Related]

  • 6. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.
    Kassiri Z, Zhong J, Guo D, Basu R, Wang X, Liu PP, Scholey JW, Penninger JM, Oudit GY.
    Circ Heart Fail; 2009 Sep 20; 2(5):446-55. PubMed ID: 19808375
    [Abstract] [Full Text] [Related]

  • 7. [Experimental study of effect of carvedilol on myocardial collagen network remodeling after acute myocardial infarction in rats].
    Liu HB, Bian SY, Yang TS, Wang L, Yi J, Yang X.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep 20; 17(9):537-40. PubMed ID: 16146598
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal failure.
    Watanabe R, Suzuki J, Wakayama K, Kumagai H, Ikeda Y, Akazawa H, Komuro I, Isobe M.
    Hypertens Res; 2016 Apr 20; 39(4):237-44. PubMed ID: 26657004
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Upregulation of angiotensin II type 2 receptor and limitation of myocardial stunning by angiotensin II type 1 receptor blockers during reperfused myocardial infarction in the rat.
    Jugdutt BI, Menon V.
    J Cardiovasc Pharmacol Ther; 2003 Sep 20; 8(3):217-26. PubMed ID: 14506547
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.
    Tao ZW, Huang YW, Xia Q, Xu QW.
    Chin Med J (Engl); 2005 Jan 20; 118(2):146-54. PubMed ID: 15667801
    [Abstract] [Full Text] [Related]

  • 13. Effects of long-term angiotensin II AT1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats.
    Richer C, Fornes P, Cazaubon C, Domergue V, Nisato D, Giudicelli JF.
    Cardiovasc Res; 1999 Jan 20; 41(1):100-8. PubMed ID: 10325957
    [Abstract] [Full Text] [Related]

  • 14. Long-acting calcium channel antagonist pranidipine prevents ventricular remodeling after myocardial infarction in rats.
    Takeuchi K, Omura T, Yoshiyama M, Yoshida K, Otsuka R, Shimada Y, Ujino K, Yoshikawa J.
    Heart Vessels; 1999 Jan 20; 14(3):111-9. PubMed ID: 10776803
    [Abstract] [Full Text] [Related]

  • 15. [Effects of irbesartan on remodeling of the left ventricular following acute myocardial infarction].
    Huang YS, Sun JH, Li XZ.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Aug 20; 15(8):476-8. PubMed ID: 12919649
    [Abstract] [Full Text] [Related]

  • 16. Comparative effects of tamoxifen and angiotensin II type-1 receptor antagonist therapy on the hemodynamic profile of the ovariectomized female rat.
    Pham-Dang ML, Clement R, Mercier I, Calderone A.
    Can J Physiol Pharmacol; 2003 Sep 20; 81(9):915-9. PubMed ID: 14614530
    [Abstract] [Full Text] [Related]

  • 17. Lung structural remodeling and pulmonary hypertension after myocardial infarction: complete reversal with irbesartan.
    Jasmin JF, Calderone A, Leung TK, Villeneuve L, Dupuis J.
    Cardiovasc Res; 2003 Jun 01; 58(3):621-31. PubMed ID: 12798435
    [Abstract] [Full Text] [Related]

  • 18. Transitory reduction in angiotensin AT2 receptor expression levels in postinfarct remodelling in rat myocardium.
    Lax CJ, Domenighetti AA, Pavia JM, Di Nicolantonio R, Curl CL, Morris MJ, Delbridge LM.
    Clin Exp Pharmacol Physiol; 2004 Aug 01; 31(8):512-7. PubMed ID: 15298543
    [Abstract] [Full Text] [Related]

  • 19. The bradykinin B1 receptor contributes to the cardioprotective effects of AT1 blockade after experimental myocardial infarction.
    Tschöpe C, Spillmann F, Altmann C, Koch M, Westermann D, Dhayat N, Dhayat S, Bascands JL, Gera L, Hoffmann S, Schultheiss HP, Walther T.
    Cardiovasc Res; 2004 Feb 15; 61(3):559-69. PubMed ID: 14962486
    [Abstract] [Full Text] [Related]

  • 20. Effects of a novel bradykinin B1 receptor antagonist and angiotensin II receptor blockade on experimental myocardial infarction in rats.
    Wu D, Lin X, Bernloehr C, Hildebrandt T, Doods H.
    PLoS One; 2012 Feb 15; 7(12):e51151. PubMed ID: 23236443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.